DSM _ Martek (Manufacture and supply of poly-unsaturated fatty acids) [2011] IECompA M11003 (17 January 2011)

DSM _ Martek (Manufacture and supply of poly-unsaturated fatty acids) [2011] IECompA M11003 (17 January 2011)

The Competition Authority found that the proposed acquisition would not substantially lessen competition in the relevant market and cleared the transaction.

Citation
[2011] IECompA M11003
Parties
Acquirer: Koninklijke DSM N.V.; Target: Martek Biosciences Corporation
Jurisdiction
Ireland
Judgment Date
17 January 2011
Procedural Posture
Merger Notification / Clearance (phase 1)
Outcome
cleared
Legal Topics
Merger Control, Manufacture and Supply of Poly Unsaturated Fatty Acids
Competition Law Merger Control Manufacture and Supply of Poly Unsaturated Fatty Acids

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 1 Authorities cited 1 Party arguments 2
Sign in to unlock

Parties

Koninklijke DSM N.V.

Acquirer

Martek Biosciences Corporation

Target

Procedural Posture

Merger Notification / Clearance (phase 1)

Legal Issues

  1. 1 Whether the proposed acquisition of Martek by DSM would substantially lessen competition in the relevant market

Ratio Decidendi

The Competition Authority found that the proposed acquisition would not substantially lessen competition in the relevant market and cleared the transaction.

Court Disposition

cleared

Orders

  • The proposed acquisition of Martek by DSM is cleared.